Cancer immunotherapy is a treatment approach that helps T lymphocytes to destroy cancerous cells. Whilst this has allowed the treatment of some advanced cancers, it does not currently work in all patients or as effectively for all types of cancer.
New research by Jingjing Zhu and co-workers within the Van den Eynde team has led to the discovery of drugs once used to treat hypertension having an interesting effect in combating the immunotherapy-resistant cancers.
More information about these promising results can be found with the full paper published in Nature and comments from the authors can be seen via the press release at the Ludwig Institute for Cancer Research.